Skip to main content
. Author manuscript; available in PMC: 2021 Dec 24.
Published in final edited form as: J Crit Care. 2019 Apr 9;52:109–114. doi: 10.1016/j.jcrc.2019.04.011

Table 2.

Urine output (Non-progress vs Progress to AKIN Stage III AKI) over the first 6 Post-FST hours

Total (n=92) Non-progress (n=69) Progress (n=23) p value
Hour 1 289.73 (34.05) 343.5 (41.57) 128.43 (39.79) 0.001
Hour 2 377 (42.58) 465.25 (50.2) 112.26 (48.8) <0.001
Hour 3 310.44 (31.62) 373.18 (37.53) 122.22 (36.46) <0.001
Hour 4 279.1 (30.87) 339.75 (37.85) 97.17 (21.7) <0.001
Hour 5 216.62 (21.67) 259.41 (26.29) 88.26 (19.1) <0.001
Hour 6 181.48 (18.56) 216.71 (22.76) 75.78 (14.69) <0.001
2 – hour total 666.73 (71.87) 808.74 (85.31) 240.7 (83.5) <0.001
3 – hour total 977.17 (98.81) 1181.93 (116.19) 362.91 (116.13) <0.001
4 – hour total 1256.28 (123.56) 1521.68 (145.42) 460.09 (134.46) <0.001
5 – hour total 1472.9 (141.01) 1781.08 (165.62) 548.35 (151.09) <0.001
6 – hour total 1654.38 (156.06) 1997.79 (183.39) 624.13 (163.74) <0.001

Table 2. The urine output in millilitres in response to the furosemide stress test is depicted above. Table 2 shows the response in patients who progressed or did not progress to AKIN stage III AKI. There was a significant difference at all time points between progressors and non-progressors to AKIN stage III AKI. Reported are the mean values with standard error in the parenthesis.